Özgür KIRBAŞ, BURAK AÇAR, Ayşe KIRBAŞ, ÖZCAN ÖZEKE

Preeclampsia as a cardiovascular risk factor

Preeclampsia, the leading cause of maternal and perinatal morbidity and mortality, has been recently considered not only a pregnancy disease but also a risk factor for developing diseases later in life. We aimed to assess the electrocardiographic interval between the peak and the end of the electrocardiographic T wave (Tp–e), Tp-e/ QT ratio and Tp–e/corrected QT (QTc) ratio as candidate markers of ventricular arrhythmias in patients with history of preeclampsia. Total of 29 patients with a history of preeclampsia and 30 controls were enrolled in the present study. Cardiometabolic risk markers were compared in women with prior history of preeclampsia vs. uncomplicated term births. Fasting lipids, blood pressure (BP) and inflammatory markers measured and electrocardiogram (Tp-e interval, Tp-e/QT, and Tp-e/ QTc ratios) results evaluated at least 12 months after delivery. QT interval (371.9± 39.2 vs. 353.0±21.1; p=0.001), QTc interval (398.8±39.5 vs. 364.4±31.1; p=0.03), Tp-e interval (66.2±10.6 vs. 41.5±5.1; p

PDF

___

Steegers EA, von Dadelszen P, Duvekot JJ, et al. Pre-eclampsia. Lancet. 2010;376(9741):631-44.

Ray JG, Vermeulen MJ, Schull MJ, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet. 2005;366(9499):1797-803.

Adams T, Yeh C, Bennett-Kunzier N, et al. Long-term maternal morbidity and mortality associated with ischemic placental disease. Semin Perinatol. 2014;38(3):146-50.

Ray JG, Schull MJ, Kingdom JC, et al. Heart failure and dysrhythmias after maternal placental syndromes: HAD MPS Study. Heart. 2012;98(15):113641.

Ray JG, Booth GL, Alter DA, et al. Prognosis after maternal placental events and revascularization: PAMPER study. Am J Obstet Gynecol. 2016 Jan;214(1):106.e1-106.e14.

Garovic VD, Bailey KR, Boerwinkle E, et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J Hypertens. 2010;28(4):826-33.

Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the american heart association. Circulation. 2011;123(11):1243-62.

Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine Tenth Edition. Philadelphia: Elsevier; 2015;662-84.

Gupta P, Patel C, Patel H, et al. T(p-e) /QT ratio as an index of arrhythmogenesis J Electrocardiol. 2008;41(6):567-74.

Kirbas O, Biberoglu EH, Kirbas A, et al. Evaluation of ventricular repolarization in pregnant women with intrahepatic cholestasis. Int J Cardiol. 2015;189:25-9.

Açar B, Yüksel M, Yayla Ç, et al. Parameters of ventricular repolarization in patients with autoimmune hepatitis. Turk Kardiyol Dern Ars. 2017;45(4):3338.

Demir M, Uyan U. Evaluation of Tp-e interval and Tp-e/QT ratio in patients with non-dipper hypertension. Clin Exp Hypertens. 2014;36(5):285-8.

Yaniel Castro-Torres, Raimundo Carmona-Puerta, Richard E Katholi. Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases. 2015;3(8):05–20.

Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856-69.

Lecarpentier É, Vieillefosse S, Haddad B, et al. Placental growth factor (PlGF) and sFlt-1 during pregnancy: physiology, assay and interest in preeclampsia. Ann Biol Clin. 2016;74(3):259-67.